Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis. Academic Article uri icon

Overview

publication date

  • August 5, 2020

Research

keywords

  • Diabetes Mellitus, Type 2
  • Diagnostic Screening Programs
  • Health Care Costs
  • Non-alcoholic Fatty Liver Disease

Identity

Scopus Document Identifier

  • 85096189589

Digital Object Identifier (DOI)

  • 10.1053/j.gastro.2020.07.050

PubMed ID

  • 32763241

Additional Document Info

volume

  • 159

issue

  • 5